– Retatrutide Prices –
Retatrutide UK Price Comparison
Tracking every major UK clinic ahead of approval. Updated weekly, independently verified.
Retatrutide is not yet licensed in the UK. The MHRA has not received a submission from Eli Lilly, and no regulated private clinic can legally prescribe or supply it at this time. When retatrutide becomes available through licensed UK providers, expected no earlier than late 2027, ThePeptideBrief will track pricing across every major clinic here, checked weekly and independently verified, in the same way we already do for our Mounjaro UK price comparison. For background on the drug itself and how it compares to existing treatments, see our Retatrutide UK guide.
| Clinic | Status | Expected Availability |
|---|---|---|
| Voy | Monitoring | Awaiting MHRA approval |
| Juniper | Monitoring | Awaiting MHRA approval |
| Numan | Monitoring | Awaiting MHRA approval |
| MedExpress | Monitoring | Awaiting MHRA approval |
| Pharmacy2U | Monitoring | Awaiting MHRA approval |
| Boots | Monitoring | Awaiting MHRA approval |
| Lloyds | Monitoring | Awaiting MHRA approval |
| Superdrug | Monitoring | Awaiting MHRA approval |
| ZAVA | Monitoring | Awaiting MHRA approval |
| CheqUp | Monitoring | Awaiting MHRA approval |
This table will switch from status tracking to live pricing the moment a clinic confirms it can prescribe retatrutide in the UK. Join the newsletter below to be notified the moment that happens.
When will retatrutide be available in the UK?
Eli Lilly has not yet submitted retatrutide for MHRA approval in the UK. Based on the current trial and regulatory timeline, most industry watchers do not expect UK availability before late 2027 at the earliest. This page exists so you do not have to search from scratch when that changes, we will update it the moment any clinic confirms availability and pricing.
Should I wait for retatrutide or start Mounjaro now?
That depends on your situation, not on which drug is newer. Mounjaro is licensed, available now and has years of real-world use behind it. Retatrutide is still years away from UK availability and its long-term profile is still being established. Our Retatrutide UK guide covers the honest comparison in full, including what the trial data actually showed and what waiting would realistically cost you in time.
What will affect the price of retatrutide when it launches?
Based on how Mounjaro and Wegovy pricing has developed in the UK, expect dose, clinic overheads and early-adopter demand to be the main factors. Newly launched GLP-1 and triple-agonist treatments typically launch at a premium before competition between clinics brings prices down over the following 12 to 18 months. We will track that shift here from day one.
Want to be first to know the moment pricing is confirmed? Join the newsletter below and we will email you as soon as this page goes live with real numbers.
Is retatrutide available in the UK yet?
No. Retatrutide is not currently licensed for use in the UK. Eli Lilly has not yet submitted the drug for MHRA approval, so no regulated UK clinic can legally prescribe or supply it.
When will retatrutide be available in the UK?
There is no confirmed date. Based on the current trial and regulatory timeline, most industry watchers do not expect UK availability before late 2027 at the earliest. This page will be updated the moment that changes.
How much will retatrutide cost in the UK?
Pricing cannot be confirmed until retatrutide is licensed and clinics begin offering it. Based on how Mounjaro and Wegovy launched, expect an initial premium price that comes down over time as more clinics offer it.
Will retatrutide be cheaper or more expensive than Mounjaro?
It is too early to say. Newly launched treatments in this category have historically launched at a higher price than established options before competition brings prices down. We will compare retatrutide and Mounjaro pricing directly once real numbers are available.
Which UK clinics will offer retatrutide first?
This is not yet known. The clinics already offering Mounjaro and Wegovy, including Voy, Juniper, Numan, Boots and others, are the most likely to add retatrutide first once it is licensed, and we are monitoring all of them.
How will I know when retatrutide pricing is confirmed?
Join the ThePeptideBrief newsletter using the sign-up below. We will email subscribers the moment any UK clinic confirms retatrutide pricing and availability, and this page will be updated with live prices at the same time.